NAC’s Longevity In US Dietary Supplement Market Swings On Comments As NDI Notifications
FDA Serves Up Request For Comments In Pre-Holiday Announcement Dish
FDA ODSP details “data, research results, and other information” it needs on NAC that could sway proposing a rulemaking to allow its continued use in supplements. One detail missing is what the agency’s asking for are NDI notifications for NAC.
